Lupin informs about press release

09 Dec 2022 Evaluate
Lupin has informed that it enclosed a Press Release as regards, launch of authorized generic version of PENNSAID (Diclofenac Sodium Topical Solution), 2% w/w of Horizon Pharma Therapeutics. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2191.80 -21.75 (-0.98%)
08-Jan-2026 11:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1769.10
Dr. Reddys Lab 1227.95
Cipla 1465.15
Zydus Lifesciences 925.95
Lupin 2191.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×